Biodesix to Present New Data on Nodify Lung Testing at CHEST 2023 Annual Meeting

03.10.2023 - Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced that new data will be presented at the CHEST Annual Meeting 2023 in Honolulu, Hawaiʻi. These presentations will provide new insight ... Seite 1

Related Keywords

,University Of South Carolina ,High Specificity Blood Based Biomarker ,Identifying Malignant Pulmonary Nodules ,Kathryn Long ,Critical Care Fellow ,Medical University ,South Carolina ,Biodesix Chart ,Iodesix Kurs ,Iodesix Aktie ,